Compare Edwards Lifesciences Corporation Common Stock (EW) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 28.9× Nuvation Bio Inc. Class A Common Stock's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | NUVB | |
|---|---|---|
Market Cap | $49.44B | $1.71B |
Volume | 3,508,027 | 5,448,712 |
Sector | Health | Health |
52-Week High | $95.18 | $9.54 |
52-Week Low | $72.65 | $3.41 |
Enterprise Value | $45.90B | $1.30B |
Typical Hold Time | — | 0 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
